Actualizar mis citas con la selección
Presentar
resultados
Dalsgaard S, Thorsteinsson E, Trabjerg BB, Schullehner J, Plana-Ripoll O, Brikell I, Wimberley T, Thygesen M, Bang Madsen K, Timmerman A, Schendel D, McGrath JJ, Mortensen PB, Pedersen CB.
Incidence rates and cumulative incidences of the full spectrum of diagnosed mental disorders in childhood and adolescence.
JAMA Psychiatry 2019:20 de noviembre. [Ref.ID 103222]
Waxmonsky JG, Pelham W 3rd, Campa A, Waschbusch DA, Li T, Marshall R, Babocsai L, Humphery H, Gnagy E, Swanson J, Hanc T, Fallahazad N, Pelham WE 4th.
A randomized controlled trial of interventions for growth suppression in children with attention-deficit/hyperactivity disorder treated with central nervous system stimulants.
J Am Acad Child Adolesc Psychiatry 2019:29 de agosto. [Ref.ID 103191]
Popova V, Daly EJ, Trivedi M, Cooper K, Lane R, Lim P, Mazzucco C, Hough D, Thase ME, Shelton RC, Molero P, Vieta E, Bajbouj M, Manji H, Drevets WC, Singh JB.
Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study.
Am J Psychiatry 2019;176:1 de junio. [Ref.ID 103133]
Josephson CB, Engbers JDT, Jette N, Patten SB, Sinqh S, Sajobi TT, Marshall D, Agha-Khani Y, Federico P, Mackie A, Macrodimitris S, McLane B, Pillay N, Sharma R, Wiebe S.
Prediction tools for psychiatric adverse effects after levetiracetam prescription.
JAMA Neurology 2019:enero. [Ref.ID 103020]
Attia E, Steinglass JE, Walsh BT, Wang Y, Wu P, Schreyer C, Wildes J, Yilmaz Z, Guarda AS, Kaplan AS, Marcus MD.
Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial.
Am J Psychiatry 2019:18 de enero. [Ref.ID 103015]
Cortese A, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, Atkinson LZ, Tessari L, Banaschewski T, Coghill D, Hollis C, Simonoff E, Zuddas A, Barbui C, Purgato M, Steinhausen HC, Shokraneh F, Xia J, Cipriani A.
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
Lancet Psychiatry 2018:7 de agosto. [Ref.ID 102788]
Actualizar mis citas con la selección